Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hand-foot-mouth disease vaccine (AIM Vaccine Co.)
- Development stage
- Preclinical
- Lead developer
- AIM Vaccine Co.
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The hand-foot-mouth disease vaccine being developed by AIM Vaccine Co. is an inactivated viral vaccine intended for the prevention of hand-foot-mouth disease (HFMD). HFMD is a contagious viral infection primarily affecting infants and children, commonly caused by enteroviruses such as Enterovirus 71 (EV71) and Coxsackievirus A16 (CV-A16). This vaccine utilizes inactivated viral particles to stimulate the host's immune system to produce neutralizing antibodies against the virus, thereby providing protective immunity. As of the current pipeline information, the candidate is in the preclinical research stage.
- Other names
- HFMD vaccineEnterovirus vaccine
Beyond the preview
Go deeper on hand-foot-mouth disease vaccine (AIM Vaccine Co.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hand-foot-mouth disease vaccine (AIM Vaccine Co.).